Right ventricle remodeling after transcatheter tricuspid leaflet repair in patients with functional tricuspid regurgitation: Lessons from the surgical experience.
cardiac magnetic resonance imaging
right ventricular failure
right ventricular remodeling
transcatheter tricuspid valve repair
tricuspid regurgitation
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
06
2022
accepted:
29
08
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
Clinically significant tricuspid regurgitation (TR) is common and associated with excess mortality. At the same time right ventricular (RV) failure is a complex clinical syndrome that results from many causes, but is often associated with long-term prognosis. Whilst results of isolated tricuspid valve (TV) surgery are often unsatisfactory and limited by the prohibitive risk of most patients, the recent development of percutaneous recovery techniques has opened new scenarios. In consideration of the complexity of the mechanisms that lead to right heart failure and RV dysfunction it is important to understand the real advantages that percutaneous TV treatment can offer, more specifically the effect of TR reduction on RV remodeling in the setting of functional tricuspid regurgitation (fTR).
Identifiants
pubmed: 36237898
doi: 10.3389/fcvm.2022.977142
pmc: PMC9551030
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
977142Informations de copyright
Copyright © 2022 Albertini, Nerla, Castriota and Squeri.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Am Coll Cardiol. 2015 Jun 2;65(21):2331-6
pubmed: 26022823
Ann Thorac Surg. 2021 Nov;112(5):1402-1409
pubmed: 33711306
JACC Cardiovasc Imaging. 2019 Mar;12(3):491-499
pubmed: 30846123
Circulation. 2019 Sep 9;140(10):836-845
pubmed: 31185724
Eur Heart J Cardiovasc Imaging. 2021 May 10;22(6):660-669
pubmed: 33387441
J Invasive Cardiol. 2021 Dec;33(12):E1005-E1007
pubmed: 34866053
JACC Cardiovasc Imaging. 2019 Apr;12(4):605-621
pubmed: 30947904
Lancet. 2019 Nov 30;394(10213):2002-2011
pubmed: 31708188
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1423-1434
pubmed: 31326430
Circulation. 2009 Oct 27;120(17):1672-8
pubmed: 19822809
Eur Heart J Cardiovasc Imaging. 2022 Jun 21;23(7):867-884
pubmed: 35079782
Eur Heart J. 2011 May;32(9):1105-13
pubmed: 21362707
J Am Soc Echocardiogr. 2016 May;29(5):392-401
pubmed: 26969137
J Am Coll Cardiol. 2012 Feb 21;59(8):703-10
pubmed: 22340261
Circ Cardiovasc Imaging. 2012 May 1;5(3):314-23
pubmed: 22447806
J Am Coll Cardiol. 2021 Jan 26;77(3):229-239
pubmed: 33478646
Pulm Circ. 2014 Mar;4(1):36-44
pubmed: 25006419
Circulation. 2011 May 10;123(18):1929-39
pubmed: 21518976
Heart. 2009 Jun;95(11):931-6
pubmed: 19321491
Am Heart J. 2008 Apr;155(4):732-7
pubmed: 18371484
Eur Respir J. 2014 May;43(5):1394-402
pubmed: 24627536
Am J Cardiol. 2010 Mar 1;105(5):721-6
pubmed: 20185023
Eur Heart J Cardiovasc Imaging. 2022 Jun 21;23(7):885-897
pubmed: 35234853
J Am Coll Cardiol. 2021 Feb 2;77(4):345-356
pubmed: 33509390
Cardiovasc Ultrasound. 2021 Mar 4;19(1):16
pubmed: 33663519
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
JACC Cardiovasc Imaging. 2019 Mar;12(3):559-560
pubmed: 30660521
J Am Coll Cardiol. 2014 Dec 23;64(24):2633-2642
pubmed: 25524343
J Am Soc Echocardiogr. 2007 Apr;20(4):405-8
pubmed: 17400120
Mayo Clin Proc. 2019 Oct;94(10):2032-2039
pubmed: 31279540
Echocardiography. 2016 Feb;33(2):299-306
pubmed: 26817801
Circ Heart Fail. 2014 Nov;7(6):911-7
pubmed: 25190672
Eur J Cardiothorac Surg. 2020 Nov 14;:
pubmed: 33188424
Circ J. 2014;78(2):385-92
pubmed: 24225337